Content of dynorphins and κ-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 8, 1997, Pages 1455-1464

  Jamensky, Neil T ^a   Gianoulakis, Christina ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Dynorphin Peptides; Ethanol; Kappa Opioid Receptors; Prodynorphin mRNA; Reinforcement

Indexed keywords

ALCOHOL; DOPAMINE; DYNORPHIN; DYNORPHIN[1-13]; DYNORPHIN[1-8]; KAPPA OPIATE RECEPTOR; MESSENGER RNA; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; PRODYNORPHIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CONTROLLED STUDY; DOPAMINE RELEASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PUTAMEN; RADIOIMMUNOASSAY; RECEPTOR DENSITY; SEPTUM PELLUCIDUM; TASTE AVERSION;

EID: 0030713011     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04476.x     Document Type: Article

References (81)

1. Cloninger CR, Bohman M, Sigvardsson S, von Knorring AL: Psychopathology in adopted-out children of alcoholics: The Stockholm adoption study, in Galanter M (ed): Recent Developments in Alcoholism. New York, Plenum Press, 1985, pp 37-51
2. Goldman D, Linnoila M: Genetic approaches to alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 10:237-242, 1986
3. Erickson K, Rusi M: Finnish selection studies on alcohol-related behaviours, in McLearn GE, Oetrich RA, Erwin EG (eds): Development of Animal Models and Pharmacokinetic Tools. Rockville, MD, NIAAA Research Monograph, 1981, pp 87-117
4. Keane B, Leonard BE: Rodent models of alcoholism: A review. Alcohol Alcohol 24:299-309, 1989
5. Erickson K: Genetic selection for voluntary alcohol consumption in the albino rat. Science 159:739-741, 1968
6. Waller MB, McBride WJ, Gatto GJ, Lumeng L, Li TK: Intragastric self-infusion of ethanol by ethanol-preferring and non-preferring lines of rats, Science 225:78-81, 1984
7. Lumeng L, Doolittle DP, Li TK: New duplicate lines of rats that differ in voluntary alcohol consumption. Alcohol 21:25-32, 1986
8. McLearn GE, Rogers DA: Differences in alcohol preference among inbred strains of mice. Q J Stud Alcohol 52:691-695, 1959
9. Hubbell CL, Abelson ML, Wild KD, Neuman R, Reid LD: Further studies of opioids and intake of sweetened alcoholic beverage. Alcohol 5:141-146, 1988
10. Pfeiffer A, Seizinger BR, Herz A: Chronic ethanol imbibition interferes with delta-, but not mu-opiate receptors. Neuropharmacology 20:1229-1232, 1981
11. Lê AD, Khanna JM, Kalant H, LeBlanc AB: Cross-tolerance between ethanol and morphine. Adv Exp Med Biol 132:771-777, 1980
12. Mayer JM, Khanna JM, Kalant H, Spero L: Cross-tolerance between ethanol and morphine in the guinea-pig ileum longitudinal muscle/myenteric-plexus preparation. Eur J Pharmacol 63:223-227, 1980
13. Reid LD, Hunter GA: Morphine and naloxone modulate intake of ethanol. Alcohol 1:33-37, 1984
14. Altshuler HL, Phillips PP, Feinhandler DA: Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688, 1980
15. Kornet M, Goosen C, van Ree JM: Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking in rhesus monkeys. Psychopharmacology 104:367-376, 1991
16. Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK, Froehlich JC: The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol-preference. Psychopharmacology 120:177-185, 1995
17. Reid LD: Endogenous opioids and alcohol-dependence-opioid alkaloids and the propensity to drink alcoholic beverages. Alcohol 13:5-12, 1996
18. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
19. O'Malley SS, Jaffe AJ, Chang G, Scottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:881-887, 1992
20. O'Malley SS: Opioid antagonists in the treatment of alcohol dependence: Clinical efficacy and prevention of relapse. Alcohol Alcohol 31:78-81, 1996
21. O'Brien CP, Volpicelli LA, Volpicelli JR: Naltrexone in the treatment of alcoholism: A clinical review. Alcohol 13:35-42, 1996
22. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ: Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314, 1988
23. Akil H, Cicero TJ: Overview of the endogenous opioid systems: Anatomical, biochemical, and functional issues, in Rodgers RJ, Cooper SJ (eds): Endorphins, Opiates and Behavioural Processes. Chichester, John Wiley & Sons Ltd., 1986, pp 1-23
24. Unterwald EM, Zukin RS: The endogenous opioidergic system, in Reid LD: Opioids, Bulimia, and Alcohol Abuse & Alcoholism. Ann Arbor, Springer-Verlag, 1990, pp 49-72
25. Charness ME: Ethanol and opioid receptor signalling. EXS 45:418-428, 1989
26. Corbett AD, Paterson SJ, McKnight AT, Magnan J: Dynorphin and dynorphin peptides are ligands for the kappa-subtype opiate receptor. Nature 299:78-81, 1982
27. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW: Endogenous opioid peptides. Multiple agonists and receptors. Nature 267:495-499, 1976
28. Wüster M, Schulz R, Herz A: The direction of opioid agonists towards μ, δ and E receptors in the mouse and the rat. Life Sci 20:163-170, 1980
29. de Waele JP, Papachristou DN, Gianoulakis C: The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic β-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J Pharmacol Exp Ther 261:788-794, 1992
30. de Waele JP, Kiianmaa K, Gianoulakis C: Spontaneous and ethanol stimulated in vitro release of β-endorphin by the hypothalamus of AA and ANA rats. Alcohol Clin Exp Res 18:1468-1473, 1994
31. Routtenberg A: Self-stimulation pathways: Origins and terminations - A three stage technique, in A. Wauquier and R. Rolls (eds): Brain-Stimulation Reward. Amsterdam, Elsevier/North Holland Biochemical Press, 1976, pp 31-39
32. Di Chiara G, Imperato A: Opposite effects of mu and kappa opiate agonists on dopamine release in nucleus accumbens and the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080, 1988
33. Yirmiya R, Taylor AN: Genetic differences in opiate receptor concentration and sensitivity to ethanol's effects. Pharmacol Biochem Behav 33:793-796, 1989
34. de Waele JP, Gianoulakis C: Enhanced activity of the brain βendorphin system by free-choice ethanol drinking in C57BL/6 but not DBA/2 mice. Eur J Pharmacol 258:119-125, 1994
35. de Waele JP, Gianoulakis C: Characterization of the μ and δ opioid receptors in the brain of the C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. Alcohol Clin Exp Res 21:754-762, 1997
36. Kiianmaa K, Hoffman PL, Tabakoff B: Antagonism of behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice. Psychopharmacology 79:291-294, 1983
37. Donzati BA, Althaus JS, Payson MM, von Voigtlander PF: Kappa agonist-induced reduction in dopamine release: Site of action and tolerance. Res Comm Chem Pathol Pharmacol 78:193-210, 1992
38. Koob GF: Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 133:177-184, 1992
39. Kuhar MJ, Ritz MC, Boja JW: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurol Sci 14:299-302, 1991
40. Samson HH, Tolliver GA, Haraguchi M, Hodge CW: Alcohol self-administration; role of mesolimbic dopamine. Ann NY Acad Sci 654:242-253, 1992
41. Wise RA, Bozarth MA: Action of drugs of abuse on brain reward systems: An update with specific attention to opiates. Pharmacol Biochem Behav 17:239-243, 1982
42. Sandi C, Borell J, Guaza C: Involvement of kappa type opioids on ethanol drinking. Life Sci 42:1067-1075, 1988
43. Spanagel R: The influence of opioid antagonists on the discriminative stimulus of ethanol. Phamacol Biochem Behav 54:645-649, 1996
44. Pohorecky LA, Patel V, Roberts P: Effects of ethanol in an open field apparatus: Modification by U50488H and WIN 44441-3. Physiol Behav 45:273-287, 1989
45. Nylander I, Hyytïa P, Forsander O, Terenius L: Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol Clin Exp Res 18:1272-1279, 1994
46. 3H-opiates to brain membranes. Life Sci 33:725-735, 1983
47. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 72:248-254, 1976
48. 3H]-U-69593 a highly selective ligand for the kappa opioid receptor. Eur J Pharmacol 109:281-284, 1985
49. Wollemann M, Benyhe S, Simon J: The kappa-opioid receptor: Evidence for the different receptor subtypes. Life Sci 52:599-611, 1992
50. Whitehouse PJ: Receptor autoradiography: Applications in neuropathology. Trends Neurosci 8:434-437, 1985
51. Nock B, Rajpara A, O'Connor LH, Cicero T: Autoradiography of [3H]U-69593 binding sites in rat brain: Evidence for kappa opioid receptor subtypes. Eur J Pharmacol 154:27-34, 1988
52. Sidman RL, Angevine JB, Pierce ET: Atlas of the Mouse Brain and Spinal Chord. Boston, Harvard University Press, 1971
53. Civelli O, Douglass J, Goldstein A, Herbert E: Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82:4291-4299, 1985
54. Young WS III, Bonner TI, Braun MR: Mesencephalic dopamine neurons regulate expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83:9827-9838, 1986
55. Wisden W, Morris BJ: In situ hybridization with synthetic oligonucleotide probes, in Wisden W, Morris BJ (eds): In Situ Hybridization Protocols for the Brain, Toronto, Harcourt, Brace and Company, 1994, pp 9-25
56. Seckl JR, Dickson KL, Fink G: Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J Neuroendocrinol 2:911-920, 1990
57. Desjardins GC, Brawer JR, Beaudet A: Estradiol is selectively neurotoxic to hypothalamic beta-endorphin neurons. Endocrinology 132:86-93, 1993
58. Rosenthal HE: A graphic method for the determination and presentation of binding parameters in a complex system. Analyt Biochem 20:525-532, 1967
59. Lahti RA, von Voigtlander PF, Barshun C: Properties of a selective kappa agonist, U-50488H. Life Sci 31:2257-2269, 1981
60. von Voigtlander PF, Lahti RA, Ludens JH: U-50488H: A selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224:7-14, 1983
61. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278, 1988
62. Wise RA, Bozarth MA: A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492, 1987
63. Spanagel R, Herz A, Shippenberg TS: The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J Neurochem 55:1734-1740, 1990
64. Spanagel R, Herz A, Shippenberg TS: Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050, 1992
65. Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM: Kappa receptor regulation of dopamine release from the striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 247:1103-1106, 1988
66. de Waele JP, Kiianmaa K, Gianoulakis C: Distribution of the μ. and δ opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 275:518-527, 1995
67. Terenius L: Reward and its control by dynorphin peptides. EXS 71:9-15, 1994
68. Hyytïa P: Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45:697-701, 1993
69. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK: Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103:467-472, 1991
70. Johnson SW, North RW: Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-490, 1992
71. Di Chiara G, Acquas E, Tanda G: Ethanol as a neurochemical surrogate of conventional reinforcers: The dopamine-opioid link. Alcohol 13:13-17, 1996
72. Spanagel R, Almeida OFX, Barti C, Shippenberg TS: Endogenous kappa-opioid systems in opiate withdrawal: Role in aversion and accompanying changes in the mesolimbic dopamine release. Psychopharmacology 115:121-127, 1994
73. Lê AD, Chow S: Reduction of ethanol intake in C57BL/6 mice by opiate receptor antagonists. Alcohol Alcohol 27:49-56, 1992
74. Cunningham CL, Niehus DR, Malott DH, Prather LK: Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology 107:385-393, 1992
75. Meliska CJ, Bartke A, McGlacken G, Jensen RA: Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in the C57BL/6 and DBA/2 mice. Pharmacol Biochem Behav 50:619-626, 1995
76. Grahame NJ, Cunningham CL: Genetic differences in intravenous cocaine self-administration between C57BL/6 and DBA/2 mice. Psychopharmacology 122:281-291, 1995
77. Grahame NJ, Cunningham CL: Intravenous ethanol self-administration in C57BL/6J and DBA/2J mice. Alcohol Clin Exp Res 21:56-62, 1997
78. Sanna E, Dildy-Mayfield JE, Harris RA: Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic M1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: Role of protein kinase C. Mol Pharmacol 45:1004-1012, 1994
79. Tabakoff B, Whelan JP, Ovchinnikova L, Nhamburo P, Yoshimura M, Hoffman PL: Quantitative changes in G-proteins do not mediate ethanol-induced downregulation of adenylyl cyclase in mouse cerebral cortex. Alcohol Clin Exp Res 19:187-194, 1995
80. Wand GS, Diehl AM, Levine MA, Wolfgang D, Samy S: Chronic ethanol treatment increases expression of inhibitory G-proteins and releases adenylylcyclase activity in the central nervous system of two lines of ethanol-sensitive mice. J Biol Chem 268:2595-2601, 1993
81. Harris RA, Allan AM: Neurochemistry of alcohol sensitivity: Genetics and brain chloride channels, in Kiianmaa K, Tabakoff B, Saito T (eds): Genetic Aspects of Alcoholism, The Finnish Foundation for Alcohol Studies. Helsinki, Finland, 1989, pp 219-228